Australia's most trusted
source of pharma news
Monday, 29 April 2024
This pharma has unveiled a major restructure to deliver US$1.5 billion in cost savings by the end of 2025 but it will come with the loss of six per cent of the company's global workforce - or 2200 jobs - by the end of this year.